Overview

Pharmacodynamic Evaluation of Antiplatelet Effect of Swallowing Versus Chewing Ticagrelor in Patients With Acute Coronary Syndrome

Status:
Recruiting

Trial end date:
2021-09-30

Target enrollment:

Participant gender:

Summary

The study aims to determine the pharmacodynamic performance in the first hour measured with verifynow, of the conventional ticagrelor loaded dose versus chewed ticagrelor in patients with acute coronary syndrome treated with percutaneous coronary intervention

Phase:

Phase 4

Details

Lead Sponsor:

Centro Hospitalario La Concepcion

Treatments:

Ticagrelor